Member News

Immutep enters into clinical trial collaboration and supply agreement with Merck KGaA, Darmstadt, Germany, and Pfizer

Immutep Limited is pleased to announce that it has entered into a clinical trial collaboration and supply agreement with Merck KGaA, Darmstadt, Germany and Pfizer Inc., to evaluate the combination of Immutep’s lead immunotherapy product candidate eftilagimod alpha…

Burnet’s qDOS Lab a new approach to bringing innovative technologies to market

Fast-tracking innovative technologies through early proof-of-concept and feasibility stages is a key aim of Burnet Institute’s new initiative, the Quick Development of Solutions Lab (qDOS Lab). Nurturing technologies through key early-stage development phases by adopting a market led approach is a primary focus…

Grimwade Medal Oration: Prof Randy Schekman – From Pond Scum to Stockholm

Thursday 20 September, 5.00–6.00 pm | Bio21 Institute Auditorium This year’s Grimwade Medallist is 2013 Nobel Laureate Prof Randy W Schekman, investigator of the Howard Hughes Medical Institute, Chair of the Advisory Council for the Aligning Science Across…

What to do when an R&D tax incentive claim goes bad

The R&D tax incentive program is the Government’s largest program designed to support business innovation. It has been reviewed multiple times, with each review concluding it provides significant benefits to the Australian economy, far beyond the cost. AusIndustry…

IT in healthcare: getting your product to market

Thursday, 20 September 2018 | 9 am–1 pm A free workshop hosted by the Department of Industry, Innovation and Science Entrepreneurs’ Programme IT in healthcare applications, devices and systems has seen rapid growth and expansion in recent times. The…

Job: Senior Consultant – Market Access Lead

New growth opportunity Market leading company Diversity of projects The company Our client is integral to all stages of the product development cycle and subsequent success for international & Australasian companies across the healthcare landscape. Their clients include…

2018 ARCS Annual Conference – Healthcare 4.0: The Data Imperative

21–23 August 2018 Royal Randwick Turf Club, Sydney ARCS Annual Conference registrations are closing on Tuesday 14 August 2018. So hurry and register now to not miss out on the fabulous program with over 230 confirmed speakers and session…

Job: Senior Regulatory Consultant

New growth opportunity Market leading company Diversity of projects The company Our client is integral to all stages of the product development cycle and subsequent success for international & Australasian companies across the healthcare landscape. Their clients include…

Sienna appoints exclusive distribution partner for mainland China

Sienna Cancer Diagnostics Ltd has appointed Shaanxi GaoYuan In Vitro Diagnostic Reagents Co. (“GaoYuan”) as the Company’s exclusive distribution partner for mainland China. The distribution agreement for mainland China is a milestone in Sienna’s geographical expansion strategy. The agreement…

Immutep TACTI-mel patient recruitment completed, operational update & Canadian IMP731 patent

Immutep today reports in its operational update that the final patient in Part B of the ongoing TACTI-mel Phase I clinical trial in Australia has now been recruited and is receiving treatment. Patients will be treated for up…

Job: Relationship Manager, CSIRO Futures

CSIRO Futures is recruiting a Relationship Manager in Melbourne. The successful applicant will work at the interface between science and industry, providing evidence backed strategic advice on how global trends and emerging technologies will impact Australian businesses, and…

BioCurate launches first round of project investments

BioCurate Pty Ltd has achieved an important milestone announcing investments in six early drug discovery projects from research groups at The University of Melbourne and Monash University. These projects represent the first tranche of investments for BioCurate: Dr…

Home

News & opinion

Member Directory

Events